Welcome : Guest

APHERESIS EQUIPMENT - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Apheresis Equipment in US$ Thousand by the following Type of Apheresis Equipment: Equipment for Therapeutic Apheresis, and Equipment for Donor Apheresis. The Global market is additionally analyzed by the following Procedures: Photopheresis, Plasmapheresis, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 14 companies including many key and niche players such as -

Asahi Kasei Medical Co., Ltd.
B Braun Melsungen AG
Cerus Corporation
Fresenius Kabi
Haemonetics Corporation
Kaneka Corporation

Click here to request a full list of companies covered in the report...

Code: MCP-1237
Price: $4950
Companies: 14
Pages: 204
Date: August 2017
Market Data Tables: 89
  Status: * New Report



TABLE OF CONTENTS


  APHERESIS EQUIPMENT (Complete Report) Pages : 204   | $4950

   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2
Data Interpretation & Reporting Level.....I-2
  
   Product Definitions and Scope of Study.....I-3  
   Apheresis Equipment – Rising Adoption of Therapeutic and Donor Apheresis Favors
  Growth.....II-1
2$200
   Donor Apheresis & Therapeutic Apheresis.....II-3
Donor Apheresis: Dominating Equipment Sales.....II-3
1$100
   Table 1: Global Blood Donations by Region - Breakdown by Whole Blood Donations and Apheresis Donations for 2013 (includes corresponding Graph/Chart).....II-41$350
   Table 2: Global Blood Donations - Apheresis Donation as % of Total Blood Donation by Geographic Region (includes corresponding Graph/Chart).....II-5
Therapeutic Apheresis to Witness Strong Growth.....II-5
1$350
   Disposable Apheresis Kits Market Benefits from Single-Use Nature of Products.....II-6
Centrifugation Technology Continues to Lead, Membrane Filtration Promises
  Growth.....II-6
Plasmapheresis Systems Dominate Apheresis Equipment Market.....II-6
1$100
   Neurology – The Major Application Area for Apheresis Equipment.....II-7
Developed Markets Continue to Lead Apheresis Equipment Market.....II-7
1$100
   Developing Nations to Lead the Charge in Future.....II-81$100
   Rising Demand for Plasma from Biopharmaceutical Companies – Opportunity to Tap.....II-9
Sustained Growth in Blood Collections Favors Apheresis Equipment Market.....II-9
1$100
   Table 3: Total Blood Collections (2016): Percentage Breakdown of Collections (Units) for Leukoreduced and Non-Leukoreduced Blood (includes corresponding Graph/Chart).....II-101$350
   Competitive Landscape.....II-11
Table 4: Leading Players in the Global Apheresis Systems Market (2016): Percentage Breakdown of Value Sales for Fresenius, Haemonetics, Terumo, and Others (includes corresponding Graph/Chart).....II-11
1$350
   Table 5: Leading Players in the Global Blood Component Collection Market (2016): Percentage Breakdown of Value Sales for Fresenius/Fenwal, Haemonetics, Terumo Corp and Others (includes corresponding Graph/Chart).....II-12
Consolidation of Blood Collectors & Healthcare Providers Puts Pricing Pressure on
  Suppliers.....II-12
1$350
   Rising Cancer Incidence to Drive Volume of Apheresis Procedures.....II-13
Table 6: Worldwide Incidence of Cancer (2010, 2020 & 2030): Number of New Cases Diagnosed (includes corresponding Graph/Chart).....II-13
1$350
   Table 7: World Cancer Incidence (2012): Number of New Cancer Cases Reported (in Thousands) by Geographic Region and Gender (includes corresponding Graph/Chart).....II-14

Table 8: World Cancer Mortality (2012): Number of Cancer-Related Deaths (in Thousands) by Geographic Region and Gender (includes corresponding Graph/Chart).....II-14
1$350
   Table 9: New Cancer Cases in the World by Affected Site (2012) (In Thousands) (includes corresponding Graph/Chart).....II-15
Technological Advancements and Novel Indications Augur Well for Apheresis
  Market.....II-15
1$350
   Blood Supply Shortage & Safety Concerns Bode Well for Apheresis Market.....II-16
Photopheresis: A Popular Therapeutic Apheresis Procedure.....II-16
1$100
   Plasmapheresis Continues to Lead the Apheresis Market.....II-17
Plateletpheresis Emerges as the ‘Treatment of Choice’.....II-17
1$100
   Increase in Number of Platelet Donors Drives Apheresis Procedures.....II-18
Pediatrics: An Unexplored Domain in Therapeutic Apheresis.....II-18
Automated Blood Processing Systems in Open Heart Surgeries.....II-18
1$100
   CFA – An Effective Way to Pull Up Cold Hemagglutinin Disease.....II-19
Improving Healthcare Expenditure to Drive Demand.....II-19
1$100
   Table 10: Healthcare Spending as % of GDP by Geographic Region (2016) (includes corresponding Graph/Chart).....II-201$350
   Table 11: Per Capita Healthcare Spending (in $) in Select Developed Countries for the Year 2016 (includes corresponding Graph/Chart).....II-21
Aging Population: A Strong Growth Driver.....II-21
1$350
   Table 12: Global Aging Population in Select Regions/ Countries: Population of 60+ Individuals in ‘000s and as a Percentage of Total Population for 2015 & 2050 (includes corresponding Graph/Chart).....II-221$350
   Table 13: Life Expectancy at Birth (in Years) in Select Countries for 2016 (includes corresponding Graph/Chart).....II-23
Key Challenges & Issues.....II-23
Lack of Awareness among Patients Restrains Market Growth.....II-23
Vendors’ Attitude Hampers Growth Prospects of Therapeutic Apheresis.....II-23
1$350
   Development of Inexpensive Apheresis Therapies.....II-24
Shortage of Qualified Donors.....II-24
Challenges for Therapeutic Apheresis in the Unexplored Pediatrics Segment.....II-24
1$100
   Apheresis – The Definition.....II-25
Apheresis Vs Whole Blood Collection.....II-25
1$100
   Comparison of Apheresis and Whole Blood Collection.....II-26
The Process of Apheresis – An Overview.....II-26
Blood Components.....II-26
1$100
   Apheresis Procedure.....II-27
Duration, Frequency, and Efficiency of Apheresis.....II-27
Segregation of Blood Components.....II-27
Centrifugation.....II-27
1$100
   Centrifugal Cell Separators.....II-28
Filtration.....II-28
Side Effects.....II-28
Types of Apheresis Procedures.....II-28
Plasmapheresis.....II-28
1$100
   Plasma Exchange and Plasmapheresis: The Difference.....II-29
Therapeutic Plasma Exchange (TPE) or Plasma Exchange.....II-29
TPE: Abnormal Components Removed from Blood.....II-29
1$100
   Plasmapheresis: Potential Uses Discovered in the Early Years.....II-30
Potential Use of Plasmapheresis in Select Diseases Discovered in the Early
  Years.....II-30
Erythrocytapheresis.....II-30
Plateletpheresis.....II-30
1$100
   Leukapheresis.....II-31
Photopheresis.....II-31
Functioning of THERAKOS™ – A Typical Photopheresis System.....II-31
Lipidpheresis.....II-31
1$100
   Cytapheresis.....II-32
Stem Cell Collection.....II-32
Apheresis – A Review of Segmentation.....II-32
Donor Apheresis.....II-32
Process of Donor Apheresis.....II-32
1$100
   Automated Blood Donation Procedures.....II-33
Safety of the Donor.....II-33
1$100
   Blood Components Required by Different Patients.....II-34
Automated Apheresis.....II-34
1$100
   Therapeutic Apheresis: An Introduction.....II-35
Therapeutic Apheresis Techniques.....II-35
1$100
   Applications of Therapeutic Apheresis.....II-362$200
   Categories of Indications for Therapeutic Apheresis.....II-381$100
   Therapeutic Apheresis is Remedial for Various Diseases.....II-39
Indications for Therapeutic Apheresis.....II-39
1$100
   Type of Therapeutic Apheresis Procedure Used in Different Medication
  Conditions.....II-40
Emerging Applications of Therapeutic Apheresis.....II-40
1$100
   Cost of Select Therapeutic Apheresis Procedures: An Overview.....II-41
1. Photopheresis in GVHD (Graft-Versus-Host Disease).....II-41
2. Lipid Apheresis (LDL Apheresis).....II-41
3. Plasmapheresis and Other Procedures.....II-41
Therapeutic Apheresis: What is the Risk Involved?.....II-41
1$100
   Replacement Fluid in Therapeutic Apheresis.....II-421$100
   Replacement Fluids Used in Therapeutic Apheresis.....II-43
Various Replacement Fluids in Use.....II-43
Select Replacement Fluids and their Limitations.....II-43
Table 14: Fluid Balance in Fluid Replacement.....II-43
1$350
   Table 15: Volume Exchange of Plasma Constituents (includes corresponding Graph/Chart).....II-44

Table 16: Removal of IgM and IgG by Plasma Exchange Volume (includes corresponding Graph/Chart).....II-44
1$350
   Table 17: Therapeutic Apheresis: Percentage Decrease and Restoration of Blood Components.....II-45
Complications Involved and Suggested Treatment in the Therapeutic Apheresis
  Procedure.....II-45
1$350
   Therapeutic Plasmapheresis with Fresh Frozen Plasma (FFP) Replacement.....II-461$100
   Red Blood Cells (RBCs).....II-47
White Blood Cells (WBCs).....II-47
Platelets.....II-47
1$100
   Sources of Blood Plasma.....II-48
Facts About Plasma and its Donation.....II-48
1$100
   Pre-requisites for Plasma Donors.....II-49
The Complex Process of Becoming a Donor.....II-49
1$100
   Medical Screening.....II-50
The Process of Plasma Donation.....II-50
Select IQPP-authorized Plasma Collection Centers (US).....II-50
1$100
   Ionic Composition of Blood.....II-51
Types of Blood.....II-51
1$100
   General Facts about Blood.....II-52
General Uses of Blood.....II-52
Blood – Global Facts.....II-52
1$100
   Fresenius Introduces 6008 CAREsystem.....II-53
Terumo BCT Launches Correct Connect System.....II-53
FDA Approves IDE Supplement for Cerus’ INTERCEPT Blood System.....II-53
Health Canada Approves WBCD and PMN Cell Collection Protocols for Spectra
  Optia.....II-53
USFDA Clears PMN Protocol for Terumo’s Spectra Optia.....II-53
1$100
   Haemonetics Gains FDA Approval for NexSys PCS Plasmapheresis System.....II-54
Terumo BCT Receives CE Mark for Spectra Optia® Apheresis System.....II-54
Terumo BCT Enters into Distribution Agreement with B Medical Systems.....II-54
Mallinckrodt Takes Over Therakos.....II-54
HemaCare Sells Therapeutic Apheresis Assets to Fresenius.....II-54
Terumo BCT Files FDA Submission to Improve Blood Supply Safety.....II-54
1$100
   Fenwal Autopheresis-C Instruments Donated for Ebola Virus Study.....II-55
Terumo opens Production Facility in Vietnam.....II-55
Terumo Collaborates with Kaneka.....II-55
Terumo to Distribute Therakos Products in Latin America.....II-55
Terumo Enters Distribution Agreement with Therakos.....II-55
1$100
   Asahi Kasei Medical Co., Ltd. (Japan).....II-56
B Braun Melsungen AG (Germany).....II-56
Cerus Corporation (USA).....II-56
1$100
   Fresenius Kabi (Germany).....II-57
Haemonetics Corporation (USA).....II-57
1$100
   Kaneka Corporation (Japan).....II-58
Kawasumi Laboratories, Inc. (Japan).....II-58
Mallinckrodt Pharmaceuticals (Ireland).....II-58
1$100
   Medica SpA (Italy).....II-59
NIKKISO Europe GmbH (Germany).....II-59
Terumo BCT, Inc. (USA).....II-59
2$200
   Table 18: World Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-611$350
   Table 19: World Historic Review for Apheresis Equipment by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-621$350
   Table 20: World 14-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-631$350
   Table 21: World Recent Past, Current & Future Analysis for Equipment for Therapeutic Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-641$350
   Table 22: World Historic Review for Equipment for Therapeutic Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-651$350
   Table 23: World 14-Year Perspective for Equipment for Therapeutic Apheresis by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-661$350
   Table 24: World Recent Past, Current & Future Analysis for Equipment for Donor Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-671$350
   Table 25: World Historic Review for Equipment for Donor Apheresis by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-681$350
   Table 26: World 14-Year Perspective for Equipment for Donor Apheresis by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), and Rest of World Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-691$350
   Table 27: World Recent Past, Current & Future Analysis for Apheresis Equipment by Procedure Type - Photopheresis, Plasmapheresis, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....II-701$350
   Table 28: World Historic Review for Apheresis Equipment by Procedure Type - Photopheresis, Plasmapheresis, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....II-711$350
   Table 29: World 14-Year Perspective for Apheresis Equipment by Procedure Type - Percentage Breakdown of Dollar Sales for Photopheresis, Plasmapheresis, and Others Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....II-721$350
   A. Market Analysis.....III-1
Apheresis Market – An Overview.....III-1
Blood Donations.....III-1
1$75
   Table 30: Blood Donation in the US (2016): Percentage Breakdown of Number of Blood Donations by Type - Apheresis Donation and Whole Blood Donation (includes corresponding Graph/Chart).....III-2

Table 31: Blood Transfusions per 1000 population in the US (2012-2017) (includes corresponding Graph/Chart).....III-2
1$200
   Blood Supply and Demand in the US – A Fact Sheet.....III-3
Criteria for Platelet Donation.....III-3
Criteria for Double Red Cell Donation.....III-3
1$75
   Plasma Donations.....III-4
Table 32: Plasma Collection in the US for 2012, 2014 & 2016 (In Million Liters) (includes corresponding Graph/Chart).....III-4
Therapeutic Apheresis Registers Strong Growth.....III-4
1$200
   Table 33: US Market for Apheresis Equipment (2017): Percentage Breakdown of Revenues Generated Through Procedures by Therapeutic Area (includes corresponding Graph/Chart).....III-5
Competitive Scenario.....III-5
1$200
   Table 34: Leading Players in the US Whole Blood Collection Market (2016): Percentage Breakdown of Volume Sales for Fresenius, Haemonetics, Terumo and Others (includes corresponding Graph/Chart).....III-6

Table 35: Leading Players in the US Market for Therapeutic Apheresis in Neurological Disorders (2016): Percentage Breakdown of Revenues for Fresenius Kabi, Haemonetics, Terumo BCT, and Others (includes corresponding Graph/Chart).....III-6

Table 36: Leading Players in the US Market for Therapeutic Apheresis in Hematology and Oncology Disorders (2016): Percentage Breakdown of Revenues for Fresenius Kabi, Terumo BCT, and Others (includes corresponding Graph/Chart).....III-6
1$200
   Consolidation of Blood Collectors and Healthcare Providers Puts Pricing Pressure on
  Suppliers.....III-7
An Overview of Regulatory Environment and Reimbursement Scenario.....III-7
1$75
   Reimbursement Policies to Create Growth Opportunities for Therapeutic
  Apheresis.....III-8
Medicaid Coverage for Therapeutic Apheresis by Various Conditions.....III-8
Medicaid Coverage for Therapeutic Plasma Exchange.....III-8
2$150
   Table 37: Payment Rates for Apheresis Procedures in 2016 & 2017 (In US$) (includes corresponding Graph/Chart).....III-10
Product Launches.....III-10
1$200
   Strategic Corporate Developments.....III-111$75
   Select Players.....III-122$150
   B. Market Analytics.....III-14
Table 38: US Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-14
1$200
   Table 39: US Historic Review for Apheresis Equipment by Segment – Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-151$200
   Table 40: US 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-161$200
   A. Market Analysis.....III-17
Outlook.....III-17
Product Approval.....III-17
1$75
   B. Market Analytics.....III-18
Table 41: Canadian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-18
1$200
   Table 42: Canadian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-191$200
   Table 43: Canadian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-201$200
   A. Market Analysis.....III-21
Outlook.....III-21
Therapeutic Apheresis Market – An Overview.....III-21
Growing Demand for Cancer Treatments Drives Plateletpheresis Market.....III-21
Select Players.....III-21
2$150
   B. Market Analytics.....III-23
Table 44: Japanese Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-23
1$200
   Table 45: Japanese Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-241$200
   Table 46: Japanese 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-251$200
   A. Market Analysis.....III-26
Outlook.....III-26
Blood Banks in Europe.....III-26
Table 47: Leading Players in the European Whole Blood Collection Market (2016): Percentage Breakdown of Volume Sales for Fresenius, MacoPharma, Terumo and Others (includes corresponding Graph/Chart).....III-26
1$200
   Strategic Corporate Development.....III-27
B. Market Analytics.....III-27
Table 48: European Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-27
1$200
   Table 49: European Historic Review for Apheresis Equipment by Geographic Region - France, Germany, Italy, UK, Spain, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-281$200
   Table 50: European 14-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of Europe Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-291$200
   Table 51: European Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-301$200
   Table 52: European Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-311$200
   Table 53: European 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-321$200
   Market Analysis.....III-33
Table 54: French Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-33
1$200
   Table 55: French Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-341$200
   Table 56: French 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-351$200
   A. Market Analysis.....III-36
Outlook.....III-36
Product Launch.....III-36
Select Players.....III-36
2$150
   B. Market Analytics.....III-38
Table 57: German Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-38
1$200
   Table 58: German Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-391$200
   Table 59: German 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-401$200
   A. Market Analysis.....III-41
Outlook.....III-41
Medica SpA – A Select Player.....III-41
1$75
   B. Market Analytics.....III-42
Table 60: Italian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-42
1$200
   Table 61: Italian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-431$200
   Table 62: Italian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-441$200
   Market Analysis.....III-45
Table 63: UK Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-45
1$200
   Table 64: UK Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-461$200
   Table 65: UK 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-471$200
   Market Analysis.....III-48
Table 66: Spanish Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-48
1$200
   Table 67: Spanish Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-491$200
   Table 68: Spanish 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-501$200
   A. Market Analysis.....III-51
Outlook.....III-51
Mallinckrodt Pharmaceuticals (Ireland) – A Key Player.....III-51
1$75
   B. Market Analytics.....III-52
Table 69: Rest of Europe Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-52
1$200
   Table 70: Rest of Europe Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-531$200
   Table 71: Rest of Europe 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-541$200
   Market Analysis.....III-55
Table 72: Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Geographic Region - Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-55
1$200
   Table 73: Asia-Pacific Historic Review for Apheresis Equipment by Geographic Region - Australia, China and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-561$200
   Table 74: Asia-Pacific 14-Year Perspective for Apheresis Equipment by Geographic Region - Percentage Breakdown of Dollar Sales for Australia, China and Rest of Asia-Pacific Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-571$200
   Table 75: Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-581$200
   Table 76: Asia-Pacific Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-591$200
   Table 77: Asia-Pacific 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-601$200
   A. Market Analysis.....III-61
Outlook.....III-61
Strategic Corporate Development.....III-61
1$75
   B. Market Analytics.....III-62
Table 78: Australian Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-62
1$200
   Table 79: Australian Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-631$200
   Table 80: Australian 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-641$200
   Market Analysis.....III-65
Table 81: Chinese Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-65
1$200
   Table 82: Chinese Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-661$200
   Table 83: Chinese 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-671$200
   A. Market Analysis.....III-68
Outlook.....III-68
Strategic Corporate Development.....III-68
1$75
   B. Market Analytics.....III-69
Table 84: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-69
1$200
   Table 85: Rest of Asia-Pacific Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-701$200
   Table 86: Rest of Asia-Pacific 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-711$200
   A. Market Analysis.....III-72
Outlook.....III-72
Strategic Corporate Developments.....III-72
1$75
   B. Market Analytics.....III-73
Table 87: Rest of World Recent Past, Current & Future Analysis for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2016 through 2024 (includes corresponding Graph/Chart).....III-73
1$200
   Table 88: Rest of World Historic Review for Apheresis Equipment by Segment - Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2011 through 2015 (includes corresponding Graph/Chart).....III-741$200
   Table 89: Rest of World 14-Year Perspective for Apheresis Equipment by Segment - Percentage Breakdown of Dollar Sales for Equipment for Therapeutic Apheresis and Equipment for Donor Apheresis Markets for Years 2011, 2017 & 2024 (includes corresponding Graph/Chart).....III-751$200
  
Total Companies Profiled: 14 (including Divisions/Subsidiaries - 20)

Region/Country Players

The United States 8 Japan 3 Europe 9 Germany 5 Italy 3 Rest of Europe 1
Click here to request a full table of contents and more details on this project.